These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1430391)

  • 21. Agminated atypical (dysplastic) nevi: case report and review of the literature.
    Marghoob AA; Blum R; Nossa R; Busam KJ; Sachs D; Halpern A
    Arch Dermatol; 2001 Jul; 137(7):917-20. PubMed ID: 11453811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo confocal microscopy for detection and grading of dysplastic nevi: a pilot study.
    Pellacani G; Farnetani F; Gonzalez S; Longo C; Cesinaro AM; Casari A; Beretti F; Seidenari S; Gill M
    J Am Acad Dermatol; 2012 Mar; 66(3):e109-21. PubMed ID: 21742408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reexcision perineural invasion. Not a sign of malignancy.
    Stern JB; Haupt HM
    Am J Surg Pathol; 1990 Feb; 14(2):183-5. PubMed ID: 2301701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biopsy diagnoses of clinically atypical pigmented lesions of the head and neck in adults.
    Udovenko O; Griffin JR; Elston DM
    Am J Dermatopathol; 2014 Oct; 36(10):829-31. PubMed ID: 25247672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation between clinical, dermatoscopic, and histopathologic variables in atypical melanocytic nevi].
    Morales-Callaghan AM; Castrodeza-Sanz J; Martínez-García G; Peral-Martínez I; Miranda-Romero A
    Actas Dermosifiliogr; 2008 Jun; 99(5):380-9. PubMed ID: 18501170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysplastic nevi with severe atypia: Long-term outcomes in patients with and without re-excision.
    Engeln K; Peters K; Ho J; Jedrych J; Winger D; Ferris LK; Patton T
    J Am Acad Dermatol; 2017 Feb; 76(2):244-249. PubMed ID: 27838051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysplastic naevi: to shave, or not to shave? A retrospective study of the use of the shave biopsy technique in the initial management of dysplastic naevi.
    Armour K; Mann S; Lee S
    Australas J Dermatol; 2005 May; 46(2):70-5. PubMed ID: 15842396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi).
    Ko CJ; McNiff JM; Glusac EJ
    J Cutan Pathol; 2009 Oct; 36(10):1063-8. PubMed ID: 19187111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What Is the Best Method for Removing Biopsy-Proven Atypical Nevi? A Comparison of Margin Clearance Rates Between Reshave and Full-Thickness Surgical Excisions.
    Jeon H; Wang YJ; Smart C
    Dermatol Surg; 2015 Sep; 41(9):1020-3. PubMed ID: 26230329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Financial Implications of Positive Margins After Nonmelanoma Skin Cancer Resection: A Longitudinal Evaluation.
    Ranganath B; Teixeira RM; Patel T; Garza R; Murphy RX
    Ann Plast Surg; 2021 Jul; 87(1):80-84. PubMed ID: 33009148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reply: surgical margins for possibly malignant melanocytic lesions and the overdiagnosis of melanoma.
    Piepkorn MW; Barnhill RL; Elder DE
    J Am Acad Dermatol; 2014 Sep; 71(3):590. PubMed ID: 25128110
    [No Abstract]   [Full Text] [Related]  

  • 32. To scoop or not to scoop: the diagnostic and therapeutic utility of the scoop-shave biopsy for pigmented lesions.
    Mendese G; Maloney M; Bordeaux J
    Dermatol Surg; 2014 Oct; 40(10):1077-83. PubMed ID: 25229784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathologic characteristics of dysplastic nevi. Limited association of conventional histologic criteria with melanoma risk group.
    Ahmed I; Piepkorn MW; Rabkin MS; Meyer LJ; Feldkamp M; Goldgar DE; Skolnick MH; Zone JJ
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):727-33. PubMed ID: 2347959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Atypical lentiginous nevus: a clinical and histopathologic study of 14 cases].
    Agustí-Mejias A; Messeguer Badia F; García Ruiz R; Oliver Martínez V; Alegre de Miquel V
    Actas Dermosifiliogr; 2012 Jun; 103(5):394-400. PubMed ID: 22421501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanocytic nevi simulant of melanoma with medicolegal relevance.
    Massi G
    Virchows Arch; 2007 Sep; 451(3):623-47. PubMed ID: 17653760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic.
    McGinnis KS; Lessin SR; Elder DE; Guerry D; Schuchter L; Ming M; Elenitsas R
    Arch Dermatol; 2002 May; 138(5):617-21. PubMed ID: 12020222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melanoma risk in individuals with clinically atypical nevi.
    Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
    Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermatopathology updates on melanocytic lesions.
    Cheung WL; Smoller BR
    Dermatol Clin; 2012 Oct; 30(4):617-22, vi. PubMed ID: 23021049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adequacy of conservative 2- to 3-mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: Retrospective case series at a tertiary academic institution.
    Soleymani T; Swetter SM; Hollmig ST; Aasi SZ
    J Am Acad Dermatol; 2020 Jul; 83(1):254-255. PubMed ID: 31972255
    [No Abstract]   [Full Text] [Related]  

  • 40. Reexcision Perineural Invasion and Epithelial Sheath Neuroma Possibly on a Spectrum of Postinjury Reactive Hyperplasia Mediated by IL-6.
    Wang JY; Nuovo G; Kline M; Magro CM
    Am J Dermatopathol; 2017 Jan; 39(1):49-52. PubMed ID: 27749287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.